TrialInvestigational new drugs2022

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial.

Leiping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.